20-45110769-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_145652.4(WFDC5):āc.92C>Gā(p.Ser31Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145652.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFDC5 | NM_145652.4 | c.92C>G | p.Ser31Trp | missense_variant | 2/4 | ENST00000372789.6 | NP_663627.1 | |
WFDC5 | NM_001395506.1 | c.92C>G | p.Ser31Trp | missense_variant | 4/6 | NP_001382435.1 | ||
WFDC5 | XM_047439930.1 | c.98C>G | p.Ser33Trp | missense_variant | 1/3 | XP_047295886.1 | ||
WFDC5 | XM_011528601.2 | c.92C>G | p.Ser31Trp | missense_variant | 3/5 | XP_011526903.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFDC5 | ENST00000372789.6 | c.92C>G | p.Ser31Trp | missense_variant | 2/4 | 1 | NM_145652.4 | ENSP00000361875.4 | ||
WFDC5 | ENST00000307971.7 | c.92C>G | p.Ser31Trp | missense_variant | 2/4 | 5 | ENSP00000312381.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250218Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135314
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461612Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727084
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at